Research and Markets: Dementia-Pipeline Insights - Reviews Key Players Involved in the Therapeutics Development for Dementia and Also Provides Company Profiling

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/92fh3m/dementiapipeline) has announced the addition of the "Dementia-Pipeline Insights" report to their offering.

This Dementia-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Dementia. This report provides information on therapeutics development for Dementia, dealing with all the pipeline drugs, comparative analysis at various stages, covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies' information involved in the development of the therapeutic products. It also has highlighted the discontinued and dormant products.

Scope

  • The report provides a snapshot of the global therapeutics landscape of Dementia
  • The report provides pipeline products under the drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Dementia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Dementia and also provides company profiling
  • The report also gives information for dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

  • Dementia Overview
  • Dementia Pipeline Therapeutics
  • Dementia Therapeutics under Development by Companies
  • Dementia Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Dementia Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Dementia Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Dementia Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Dementia - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Dementia - Discontinued Products
  • Dementia - Dormant Products
  • Companies Involved in Therapeutics Development for Dementia

For more information visit http://www.researchandmarkets.com/research/92fh3m/dementiapipeline.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals